Market revenue in 2022 | USD 245.7 million |
Market revenue in 2030 | USD 373.8 million |
Growth rate | 5.4% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Allografts |
Historical data | 2016 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , U.S. , UK , Japan , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 50.18% in 2022. Horizon Databook has segmented the China orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
Research has also specified that obesity increases one’s risk of developing osteoarthritis later in life. The country has one of the highest numbers of overweight people, and obesity is a major public health concern. Thus, incidence of orthopedic conditions, such as osteoarthritis, is expected to increase over the forecast period owing to the aforementioned factors.
In January 2018, Vericel Corporation collaborated with Innovative Cellular Therapeutics (ICT) in China to develop and distribute MACI & other Vericel products in South Korea, Singapore, Greater China, and other countries in the region. Such initiatives are expected to support growth of the country’s market during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the China orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into China orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account